Sickle Cell Disease: Current Drug Treatments and Functional Foods with Therapeutic Potential

Area of Science:

• Genetics and Hematology
• Nutritional Science
• Pharmacology

Background:

• Sickle cell disease (SCD) is a prevalent genetic blood disorder caused by a mutation in the beta-globin gene, leading to chronic pain, organ damage, and increased infection risk.
• Current treatments for SCD are being evaluated through rigorous randomized controlled trials.

Purpose of the Study:

• To review current treatments for SCD from randomized controlled trials.
• To analyze the potential of functional foods as a complementary strategy for SCD management.
• To explore the use of bioactive compounds in functional foods for SCD.

Main Methods:

• Literature review of randomized controlled trials for SCD treatments.
• Analysis of scientific literature on functional foods and bioactive compounds.
• Exploration of potential therapeutic applications in SCD.

Main Results:

• Randomized trials indicate promising results for specific pharmaceutical interventions in SCD.
• Functional foods, particularly those enriched with bioactive compounds, demonstrate potential as complementary therapies.
• Bioactive compounds present a potential avenue for novel SCD management strategies.

Conclusions:

• Both pharmaceutical interventions and functional foods show therapeutic potential for managing SCD.
• Further research is essential to validate the clinical efficacy, optimal dosages, and specific mechanisms of bioactive compounds in SCD.
• Functional foods may offer a cost-effective and accessible complementary approach to SCD care.